Abstract: Systems and methods can leverage images of remotely captured items to extract information, populate forms, authenticate users, and perform other actions.

Abstract: Techniques for automatic extraction and verification of location data are disclosed. In some embodiments, a web crawler is configured to identify uniform resource locators (URLs), including a URL for a website associated with a target entity. The web crawler is further configured to fetch a subset of webpages from the website associated with the target entity. The web crawler may restrict the webpages that are fetched from the website based, at least in part, on patterns in the first website that are indicative of where reliable location information may be found. The web crawler further identifies a primary location of the target entity within at least one webpage in the subset of webpages, populating and/or verifying the primary location of the target entity in an entity profile. The entity profile may be consumed by client applications to execute location-aware and/or location dependent functions.

Abstract: Techniques for automatic extraction and verification of location data are disclosed. In some embodiments, a web crawler is configured to identify uniform resource locators (URLs), including a URL for a website associated with a target entity. The web crawler is further configured to fetch a subset of webpages from the website associated with the target entity. The web crawler may restrict the webpages that are fetched from the website based, at least in part, on patterns in the first website that are indicative of where reliable location information may be found. The web crawler further identifies a primary location of the target entity within at least one webpage in the subset of webpages, populating and/or verifying the primary location of the target entity in an entity profile. The entity profile may be consumed by client applications to execute location-aware and/or location dependent functions.

Abstract: Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.

Abstract: Provided herein are processes for the preparation of heteroaryl carboxylic acids.

Abstract: Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.

Abstract: Provided herein are processes for the preparation of heteroaryl carboxylic acids.

Abstract: Systems and methods can leverage images of remotely captured items to extract information, populate forms, authenticate users, and perform other actions.

Abstract: Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases cases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.

Abstract: Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseeases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.

Abstract: Provided herein are processes for the preparation of heteroaryl carboxylic acids.

Abstract: A vehicle advertising system comprises a processor configured to perform operations in response to instructions from a predefined instruction set, a memory, and an advertisement module comprising instructions selected from the instruction set. The instructions when executed on the processor are operable to receive identification and financing information regarding a specific vehicle for sale, to generate a first advertisement formatted for presentation in a search engine result listing based on at least the received identification information and the received financing information, to generate a second advertisement formatted for presentation on a vehicle dealer website landing page associated with the first advertisement and based on at least the received identification information and the received financing information, and to provide a predicted effectiveness score on at least one of the first advertisement and the second advertisement before publication of the at least one advertisement.

Abstract: Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseeases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.

Abstract: Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.

Abstract: The present disclosure provides systems and methods for supplying solid-ink pellets from a container to an image-forming device. The system includes a delivery tube within the container, with one or more openings to receive solid-ink pellets from the container. An agitating structure coupled to the delivery tube disturbs the solid ink pellets. The movement of the delivery tube moves the agitating structure, resulting in disturbing the solid-ink pellets and maintaining flowability of the pellets to the image-forming device.

Abstract: The present disclosure provides systems and methods for supplying solid-ink pellets from a container to an image-forming device. The system includes a delivery tube within the container, with one or more openings to receive solid-ink pellets from the container. An agitating structure coupled to the delivery tube disturbs the solid ink pellets. The movement of the delivery tube moves the agitating structure, resulting in disturbing the solid-ink pellets and maintaining flowability of the pellets to the image-forming device.

Abstract: A carbonation beverage cap which has a generally cylindrical shaped bottle adapter having a top middle portion and a raised perimeter aperture disposed on the top middle portion of the bottle adapter. A threaded adapter is coupled to a top portion of the bottle adapter, the threaded adapter having a top centered aperture disposed on a top middle portion of the threaded adapter. A bottom nipple is disposed on a bottom portion of the carbonation beverage cap that a gas hose or a carbonation stone can be coupled to to disperse carbon dioxide gas or other carbonation into a first beverage contained in a beverage bottle.

Abstract: The present disclosure provides systems and methods for supplying solid-ink pellets from a container to an image-forming device. The system includes a delivery tube within the container, with one or more openings to receive solid-ink pellets from the container. An agitating structure coupled to the delivery tube disturbs the solid ink pellets. The movement of the delivery tube moves the agitating structure, resulting in disturbing the solid-ink pellets and maintaining flowability of the pellets to the image-forming device.

Abstract: The present disclosure provides systems and methods for supplying solid-ink pellets from a container to an image-forming device. The system includes a delivery tube within the container, with one or more openings to receive solid-ink pellets from the container. An agitating structure coupled to the delivery tube disturbs the solid ink pellets. The movement of the delivery tube moves the agitating structure, resulting in disturbing the solid-ink pellets and maintaining flowability of the pellets to the image-forming device.